Mr. Burkinshaw will lead SpineSmith’s product development efforts through collaborating with the company’s mechanical engineering department and Celling Technology’s scientists. The team will focus on developing regenerative medicine products, specifically the Autologous Regenerative Therapies of the 21st Century project.
Mr. Burkinshaw has worked with multiple medical device markets in senior executive positions and as a design engineer for over 30 years. His background is in both traditional orthopedics as well as biologic companies.
Read the SpineSmith Partners and Celling Technologies news release about Mr. Burkinshaw.
Read other Becker’s coverage on Celling Technologies.
Celling Launches Res-Q for Isolation of Adult Stem Cells for Bone Growth
Stem Cell Treatment Center Opens in Texas
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
